Abstracting and Indexing

Scopus, Chemical Abstracts, CAB abstracts, Hinari, Global Health, EBSCO Publishing's Electronic Databases, Summon by serial solutions, Abstracts on Hygiene and Communicable Diseases, Proquest, Tropical Diseases Bulletin, Open j-Gate, Google Scholar, Science Central, Ulrich's Periodicals Directory, Scimago Journal Ranking, AYUSH Research Portal, Geneva Foundation for Medical Education and Research, ABC Chemistry, Biblioteca, Necker, Academic Journals Database, InfoTrac Custom & Academic Onefile (Gale), Index Medicus for South-East Asia Region (IMSEAR), CNKI scholar.

News & Events

  • JAPS is approved by UGC.
  • JAPS has implemented the CrossMark, a multi-publisher initiative from CrossRef for forthcoming articles [Read more]
  • All the contents published in JAPS are archived in Portico, which provides permanent digital archiving for scholarly journals.
  • COPE Guidelines for Peer Reviewers.
  • Reviewers invited: Eminent professionals are invited to join JAPS reviewer panel. Interested candidates may send their applications to editor@japsonline.com

Home > Past Issue

Journal of Applied Pharmaceutical Science Volume: 3, Issue: 2, February, 2013
DOI: 10.7324/JAPS.2013.30210
ISSN 2231-3354

Research Article


Evaluation of cardioprotective effects of Parkia biglobosa (Jacq. Benth) Mimosaceae stem bark

Adi K., Metowogo K., Mouzou A., Lawson-Evi P., Eklu-Gadegbeku K., Agbonon A., Lamboni C., Essien K., Aklikokou K., Gbeassor M.

[Download PDF]

Abstract

Parkia biglobosa is one of the main medicinal plants used in traditional medicine to treat cardiovascular diseases in Africa. We investigated cardioprotective effects of stem bark hydro-alcoholic extract (HAE) of P. biglobosa in isoproterenol (ISO) induced myocardial infarction (MI). Four groups of five Wistar rats of each were used. Group I, control group, received per os (p.o) saline solution (5ml kg-1 b.w.) as vehicle daily for 15 days and was injected subcutaneously with the vehicle (5ml kg-1 b.w.) at an interval of 24 hours, on day 14 and 15. Group II referred to as infarcted rats, received vehicle p.o and was injected subcutaneously with isoproterenol (125 mg kg-1 b.w.) as in group I. Groups III and IV were pre-treated p.o with HAE (90 and 60 mg kg-1 b.w. respectively) daily for 15 days and was injected subcutaneously Isoproterenol (125 mg kg-1 b.w.). ISO has induced MI, characterized by significant increased (p < 0.001) of MDA, biochemical alterations, heart hypertrophy and histological changes in infarcted rats. HAE, prevented significantly (p < 0.001) induction of all these anomalies in pre-treated rats. These results suggested cardioprotective effects of P.biglobosa against ISO induced MI.

Keywords: Parkia biglobosa, isoproterenol, myocardial infarction.